Novel FABP4⁺C1q⁺ Macrophages Enhance Antitumor Immunity and Associated with Response to Neoadjuvant Pembrolizumab and Chemotherapy in NSCLC via AMPK/JAK/STAT Axis

Scientists performed single-cell RNA sequencing and identified a novel FABP4+C1q+ macrophage subtype, which exhibited stronger proinflammatory cytokine production and phagocytic ability.